Related Experiment Videos
Cardiac augmentation by phasic high intrathoracic pressure support in man
Chest
|October 1, 1983
Summary
Phasic high intrathoracic pressure support (PHIPS) improved cardiac output and left ventricular performance in patients with shock. This novel approach reduces left ventricular afterload, offering a promising new therapy for critical cardiovascular conditions.
Area of Science:
- Cardiovascular Physiology
- Critical Care Medicine
Background:
- Intrathoracic pressure significantly impacts left ventricular performance.
- Sustained increases in intrathoracic pressure can decrease cardiac output by reducing venous return.
- Phasic increases in intrathoracic pressure, without reducing venous return, may improve cardiac output in ventricular failure.
Purpose of the Study:
- To investigate the cardiovascular effects of phasic high intrathoracic pressure support (PHIPS) in patients with refractory shock.
- To determine if PHIPS can improve cardiac output and left ventricular performance.
Main Methods:
- PHIPS was applied to seven patients in intensive care using abdominal and chest wall binding during positive-pressure ventilation.
- Cardiovascular parameters including esophageal pressure, mean arterial pressure, and cardiac output were measured before and during PHIPS.
- Gated cardiac blood pool scan was used in one patient to assess ejection fraction and end-diastolic volume.
Main Results:
- PHIPS increased esophageal pressure and mean arterial pressure.
- Cardiac output significantly increased from 3.6 to 4.2 L/min during PHIPS.
- Left ventricular filling pressures remained constant, and one patient showed improved ejection fraction and decreased end-diastolic volume.
Conclusions:
- PHIPS augments left ventricular performance by reducing left ventricular afterload.
- This method shows promise for improving cardiovascular function in patients with shock.
- Further research into PHIPS as a therapeutic strategy is warranted.